Invasive procedures in the elderly after stage IV cancer diagnosis

作者: Alvin C. Kwok , Yue-Yung Hu , Christopher M. Dodgion , Wei Jiang , Gladys V. Ting

DOI: 10.1016/J.JSS.2014.08.021

关键词: Invasive ProcedureStage ivPrimary tumorQuality of lifeCancerInternal medicineProstate cancerLife expectancySurveillance, Epidemiology, and End ResultsMedicineSurgery

摘要: Abstract Background Invasive procedures are resource intense and may be associated with substantial morbidity. These harms must carefully balanced the benefits gained in life expectancy quality of life. Prior research has demonstrated an increasing aggressiveness care cancer patients at end-of-life. To better characterize surgical this setting, we sought to examine trends use invasive diagnosed metastatic on presentation. Materials methods Using Surveillance Epidemiology End Results -Medicare data, identified procedure claims from 1994–2009 for incident stage IV breast, colorectal, lung, prostate 1995–2006. We grouped into surgically relevant categories, using adaptation Clinical Classifications Software, measured utilization relative changes over time. Of 2002–2006, 96% underwent a during course their including 63% after diagnostic period, 25% last month Between 1996 2006, minimal change was observed period (+1.5%). However, there were significant increases continuing (+20.7%) (+21.5%). Procedures consistent primary tumor resection decreased, whereas those probable palliative intent unrelated increased. Conclusions Nearly all who present undergo procedures. Although overall is increasing, specific types indicate that it appropriate, enhancing vulnerable population.

参考文章(29)
Robert W Carlson, NCCN breast cancer clinical practice guidelines in oncology: an update. Journal of The National Comprehensive Cancer Network. ,(2003)
Kathleen Lang, Jonathan R Korn, David W Lee, Lisa M Lines, Craig C Earle, Joseph Menzin, Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer. ,vol. 9, pp. 227- 227 ,(2009) , 10.1186/1471-2407-9-227
Brenda Sirovich, Patricia M. Gallagher, David E. Wennberg, Elliott S. Fisher, Discretionary Decision Making By Primary Care Physicians And The Cost Of U.S. Health Care Health Affairs. ,vol. 27, pp. 813- 823 ,(2008) , 10.1377/HLTHAFF.27.3.813
Peter B. Bach, Deborah Schrag, Colin B. Begg, Resurrecting Treatment Histories of Dead Patients: A Study Design That Should Be Laid to Rest JAMA. ,vol. 292, pp. 2765- 2770 ,(2004) , 10.1001/JAMA.292.22.2765
Shaheenah Dawood, Kristine Broglio, Ana M. Gonzalez-Angulo, Aman U. Buzdar, Gabriel N. Hortobagyi, Sharon H. Giordano, Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer Journal of Clinical Oncology. ,vol. 26, pp. 4891- 4898 ,(2008) , 10.1200/JCO.2007.14.1168
Karynsa Cetin, Jennifer L. Beebe-Dimmer, Jon P. Fryzek, Richard Markus, Michael A. Carducci, Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology. ,vol. 75, pp. 1396- 1404 ,(2010) , 10.1016/J.UROLOGY.2009.07.1360
Carrie N Klabunde, Peter B Bach, Joan L Warren, Deborah Schrag, Gerald F Riley, Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Medical Care. ,vol. 40, ,(2002) , 10.1097/01.MLR.0000020942.47004.03
A. B. Mariotto, K. Robin Yabroff, Y. Shao, E. J. Feuer, M. L. Brown, Projections of the Cost of Cancer Care in the United States: 2010–2020 Journal of the National Cancer Institute. ,vol. 103, pp. 117- 128 ,(2011) , 10.1093/JNCI/DJQ495
Daniel Morgensztern, Saiama Waqar, Janakiraman Subramanian, Feng Gao, Ramaswamy Govindan, Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. Journal of Thoracic Oncology. ,vol. 4, pp. 1524- 1529 ,(2009) , 10.1097/JTO.0B013E3181BA3634